Implication of genes in the serotonergic system for vulnerability to suicidal behaviors;Implication des gènes du système sérotoninergique dans la vulnérabilité aux conduites suicidaires

Journal of Psychiatry and Neuroscience

Volumn 29, Issue 5, 2004, Pages 350-359

  Courtet, Philippe ^a,b   Jollant, Fabrice ^a,b   Castelnau, Didier ^a   Astruc, Bernard ^a   Buresi, Catherine ^c   Malafosse, Alain ^b,c  

^a LAPEYRONIE HOSPITAL   (France)

^b INSERM   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ADOPTION; ALCOHOLISM; ANGER; BIPOLAR DISORDER; ENVIRONMENTAL FACTOR; FAMILY STUDY; GENE EARLY ENVIRONMENT INTERACTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; MENTAL DISEASE; PHENOTYPE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; TWINS;

HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MONOAMINE OXIDASE; NERVE TISSUE PROTEINS; PHENOTYPE; RECEPTORS, SEROTONIN; RISK; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDE; TRYPTOPHAN HYDROXYLASE;

EID: 9644253076     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Rihmer Z. Strategies of suicide prevention: focus on health care. J Affect Disord 1996;39(2):83-91.
2. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999;156(2):181-9.
3. Mann JJ. The neurobiology of suicide. Nat Med 1998;4(1):25-30.
4. Abbar M, Courtet P, Malafosse A, Castelnau D. Epidemiologic and molecular genetic of suicidal behavior [in French]. Encephale 1996;22(4):19-24.
5. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. JAMA 1985;254(7):915-8.
6. Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996;53(12):1145-52.
7. Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, Dinwiddie SH, et al. Suicidal behaviour: an epidemiological and genetic study. Psychol Med 1998;28(4):839-55.
8. Papadimitriou GN, Linkowski P, Delarbre C, Mendlewicz J. Suicide on the paternal and maternal sides of depressed patients with a lifetime history of attempted suicide. Acta Psychiatr Scand 1991;83(6):417-9.
9. Sullivan PF, Eaves LJ, Kendler KS, Neale MC. Genetic case-control association studies in neuropsychiatry. Arch Gen Psychiatry 2001;58(11):1015-24.
10. Merikangas KR, Risch N. Will the genomics revolution revolutionize psychiatry? Am J Psychiatry 2003;160(4):625-35.
11. Greenberg BD, McMahon FJ, Murphy DL. Serotonin transporter candidate gene studies in affective disorders and personality: promises and potential pitfalls. Mol Psychiatry 1998;3(3):186-9.
12. Boularand S, Darmon MC, Mallet J. The human tryptophan hydroxylase gene. An unusual splicing complexity in the 5′-untranslated region. J Biol Chem 1995;270(8):3748-56.
13. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003;299(5603):76.
14. Abbar M, Courtet P, Amadeo S, Caer Y, Mallet J, Baldy-Moulinier M, et al. Suicidal behaviors and the tryptophan hydroxylase gene. Arch Gen Psychiatry 1995;52(10):846-9.
15. Nielsen DA, Dean M, Goldman D. Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism. Am J Hum Genet 1992;51(6):1366-71.
16. Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Linnoila M, et al. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 1999;4(4):360-8.
17. Turecki G, Zhu Z, Tzenova J, Lesage A, Seguin M, Tousignant M, et al. TPH and suicidal behavior: a study in suicide completers. Mol Psychiatry 2001;6(1):98-102.
18. Abbar M, Courtet P, Bellivier F, Leboyer M, Boulenger JP, Castelhau D, et al. Suicide attempts and the tryptophan hydroxylase gene. Mol Psychiatry 2001;6(3):268-73.
19. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V. "Serotonin depression" - a biochemical subgroup within the affective disorders? Science 1976;191(4226):478-80.
20. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 1998;55(1):33-7.
21. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, et al. Association between the tryptophan hydroxylase gene and manic depressive illness. Arch Gen Psychiatry 1999;56(1):99-101.
22. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. Am J Med Genet 1998;81(3):245-7.
23. McQuillin A, Lawrence J, Kalsi G, Chen A, Curling H, Curtis D. No allelic association between bipolar affective disorder and the tryptophan hydroxylase gene. Arch Gen Psychiatry 1999;56(1):99-101.
24. Tsai SJ, Hong CJ, Wang YC. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. Neuroreport 1999;10(18):3773-5.
25. Kirov G, Owen MJ, Jones I, McCandless F, Craddock N. Tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 1999;56(1):98-9.
26. Jonsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, et al. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 1997;247(6):297-302.
27. Manuck SB, Flory JD, Ferrell RE, Dent KM, Mann JJ, Muldoon MF. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry 1999;45(5):603-14.
28. Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelernter J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry 1997;154(10):1451-3.
29. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 1994;51(1):34-8.
30. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC, et al. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry 1998;55(7):593-602.
31. Bennett PJ, McMahon WM, Watabe J, Achilles J, Bacon M, Coon H, et al. Tryptophan hydroxylase polymorphisms in suicide victims. Psychiatr Genet 2000;10(1):13-7.
32. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, et al. Tryptophan hydroxylase gene polymorphisms are not associated with suicide. Am J Med Genet 2000;96(6):861-3.
33. Turecki G. Suicidal behavior: Is there a genetic predisposition? Bipolar Disord 2001;3(6):335-49.
34. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33(2):177-82.
35. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361(9357):598-604.
36. Hofmann HA. Functional genomics of neural and behavioral plasticity. J Neurobiol 2003;54(1):272-82.
37. Lalovic A, Turecki G. Meta-analysis of the association between tryptophan hydroxylase and suicidal behavior. Am J Med Genet 2002;114(5)533-40.
38. Bellivier F, Chaste P, Malafosse A. Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis. Am J Med Genet 2004;124B(1):87-91.
39. Rujescu D, Giegling I, Sato T, Hartmann AM, Müller HJ. Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta-analysis. Biol Psychiatry 2003;54:465-73.
40. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. TPH replication study: not! Arch Gen Psychiatry 1996;53(10):964-5.
41. Smith AD, Johnston C, Sim E, Nagy Z, Jobst KA, Hindley N, et al. Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA). Lancet 1994;344(8920):473-4.
42. Paoloni-Giacobino A, Mouthon D, Lambercy C, Vessaz M, Coutant-Zimmerli S, Rudolph W, et al. Identification and analysis of new sequence variants in the human tryptophan hydroxylase (TpH) gene. Mol Psychiatry 2000;5(1):49-55.
43. Zalsman G, Frisch A, King RA, Pauls DL, Grice DE, Gelernter J, et al. Case control and family-based studies of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents. Am J Med Genet 2001;105(5):451-7.
44. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000;57(8): 729-38.
45. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274(5292):1527-31.
46. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000;47(7):643-9.
47. Reist C, Mazzanti C, Vu R, Tran D, Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet 2001;105(4):363-8.
48. Du L, Faludi G, Palkovits M, Demeter E, Bakish D, Lapierre YD, et al. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry 1999;46(2):196-201.
49. Gorwood P, Batel P, Ades J, Hamon M, Boni C. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry 2000;48(4):259-64.
50. Bellivier F, Szoke A, Henry C, Lacoste J, Bottos C, Nosten-Bertrand M, et al. Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol Psychiatry 2000;48(4):319-22.
51. Bondy B, Erfurth A, de Jonge S, Kruger M, Meyer H. Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry 2000;5(2):193-5.
52. Courtet P, Baud P, Abbar M, Boulenger JP, Castelnau D, Mouthon D, et al. Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Mol Psychiatry 2001;6(3):338-41.
53. Ohara K, Nagai M, Tsukamoto T, Tani K, Suzuki Y. Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders. Biol Psychiatry 1998;44(7): 550-4.
54. Russ MJ, Lachman HM, Kashdan T, Saito T, Bajmakovic-Kacila S. Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide. Psychiatry Res 2000;93(1):73-8.
55. Fitch D, Lesage A, Seguin M, Trousignant M, Bankelfat C, Rouleau GA, et al. Suicide and the serotonin transporter gene. Mol Psychiatry 2001;6(2):127-8.
56. Geijer T, Frisch A, Persson ML, Wasserman D, Rockah R, Michaelovsky E, et al. Search for association between suicide attempt and serotonergic polymorphisms. Psychiatr Genet 2000;10(1):19-26.
57. Courtet P, Buresi C, Abbar M, Baud P, Boulenger JP, Castelnau D, et al. No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism. Am J Med Genet 2003;116(1 Suppl):72-6.
58. Sander T, Harms H, Dufeu P, Kuhn S, Hoehe M, Lesch KP, et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol Psychiatry 1998;43(12):908-12.
59. Hallikainen T, Saito T, Lachman HM, Volavka J, Pohjalainen T, Ryynanen OP, et al. Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol Psychiatry 1999;4(4):385-8.
60. Tiihonen J, Kuikka JT, Bergstrom KA, Karhu J, Viinamaki H, Lehtonen J, et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur J Nucl Med 1997;24(10):1253-60.
61. Bellivier F, Laplanche JL, Leboyer M, Feingold J, Bottos C, Allilaire JF, et al. Serotonin transporter gene and manic depressive illness: an association study. Biol Psychiatry 1997;41(6):750-2.
62. Evans J, Battersby S, Ogilvie AD, Smith CA, Harmar AJ, Nutt DJ, et al. Association of short alleles of a VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self harm. Neuropharmacology 1997;36(4-5):439-43.
63. Zalsman G, Frisch A, Bromberg M, Gelernter J, Michaelovsky E, Campino A, et al. Family-based association study of serotonin transporter promoter in suicidal adolescents: no association with suicidality but possible role in violence traits. Am J Med Genet 2001;105(3):239-45.
64. Oreland L, Hallman J. The correlation between platelet MAO activity and personality: short review of findings and a discussion on possible mechanisms. Prog Brain Res 1995;106:77-84.
65. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993;262(5133)578-80.
66. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995;268(5218):1763-6.
67. Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 2000;96(1):36-42.
68. Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, Hattori M, et al. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 1999;4(4):393-5.
69. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, et al. No evidence of an association between a functional monoamine oxidase a gene polymorphism and completed suicides. Am J Med Genet 2002;114(3):340-2.
70. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002;297(5582):851-4.
71. 1B receptor. Science 1994;265(5180):1875-8.
72. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ. Relationship of psychopathology to the human serotonin 1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 1999;21(2):238-46.
73. New AS, Gelernter J, Goodman M, Mitropoulou V, Koenigsberg H, Silverman J, et al. Suicide, impulsive aggression, and HTR1B genotype. Biol Psychiatry 2001;50(1):62-5.
74. Zhang HY, Ishigaki T, Tani K, Chen K, Shih JC, Miyasato K, et al. Serotonin2A receptor gene polymorphism in mood disorders. Biol Psychiatry 1997;41(7):768-73.
75. Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999;156(9):1456-8.
76. Bonnier B, Gorwood P, Hamon M, Sarfati Y, Boni C, Hardy-Bayle MC. Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry 2002;51(9):762-5.
77. Leboyer M, Bellivier F, Nosten-Bertrand M, Jouvent R, Pauls D, Mallet J. Psychiatric genetics: search for phenotypes. Trends Neurosci 1998;21(3):102-5.
78. Zuckerman M. Serotonin, impulsivity and emotionality. Behav Brain Sci 1986;9:348-349.
79. Linnoila VM, Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry 1992;53(Suppl):46-51.
80. Benjamin J, Osher Y, Lichtenberg P, Bachner-Melman R, Gritsenko I, Kotler M, et al. An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to tridimensional personality questionnaire persistence scores in normal subjects. Neuropsychobiology 2000;41(1):48-53.
81. Bellivier F, Roy I, Leboyer M. Serotonin transporter gene polymorphisms and affective disorder-related phenotypes. Curr Opin Psychiatry 2002;15:49-58.
82. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297(5580):400-3.